Rhythm Biosciences LimitedASX: RHY

FY26 Annual Report

· Issued by Rhythm Biosciences Limited via ASX

Filed with ASX ·

2026 ANNUAL REPORTRHYTHM BIOSCIENCES LIMITED (ASX:RHY)ACN 619 459 335RHYTHM’S ColoSTAT® IS A SIMPLE BLOOD TEST THAT DETECTS THE PROTEIN BIOMARKERS IN THE BLOOD, THAT ARE INDICATIVE OF THE PRESENCE OF COLORECTAL CANCER.2CONTENTS4 Key Milestones6 Company Overview 10 Non-Executive Interim Chair's...

View Attachment

6ix hasn’t read this filing yet.

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

Later from Rhythm Biosciences

All Rhythm Biosciences news releases